Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOLLO trial of aliskiren for prevention of major cardiovascular events in elderly people
2009-010170-38Phase 3Terminated
- Sponsor
- Novartis
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aliskiren in hypertension (HTN) and cardiac morbidity (2 arms), sponsored by Novartis. Primary endpoint: Primary composite cardiovascular endpoint. Started Jun 2010; status: terminated.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)cardiac morbidity
Beyond the preview
Go deeper on 2009-010170-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010170-38.